Penumbra, Inc. (PEN) est une société cotée en bourse dans le Santé secteur, opérant dans le Medical - Devices secteur d'activité. Le siège social de l'entreprise est situé à Alameda, CA, United States. Le PDG actuel est Adam Elsesser.
PEN a date d'introduction en bourse 2015-09-18, 4,500 employés à temps plein, cotée sur le NYSE, une capitalisation boursière de $13.04B.
Penumbra, Inc. is a medical device company headquartered in Alameda, California, that designs, develops, manufactures, and markets innovative vascular intervention and neurosurgical products globally. The company specializes in aspiration-based thrombectomy systems for mechanical clot removal, neurovascular embolization coiling systems for treating aneurysms, and neurovascular access systems, marketed under brands including Penumbra System, Penumbra Coil, and Neuron. Its product portfolio also encompasses neurosurgical aspiration tools, peripheral embolization devices, microcatheters, and occlusion devices, along with immersive technology solutions for patient rehabilitation. Penumbra distributes its products through direct sales teams and distributor networks to serve the interventional neuroradiology, neurosurgery, and vascular surgery markets worldwide.
